Alert: Major Price Decline (11/7/23)-Corbus Pharmaceuticals Holdings (NASDAQ: CRBP).


Corbus Pharmaceuticals Holdings (NASDAQ: CRBP) stock closed at $4.20 on 11/7/23 after a major decline of -16.7%. Relative to the market the stock has been exceptionally strong over the last nine months but has declined -23.4% during the last week.


Current PriceTarget Research Rating

CRBP’s future returns on capital are forecasted to be below the cost of capital. Accordingly, the company is expected to continue to be a modest Value Eraser.

Corbus Pharmaceuticals Holdings has a current Value Trend Rating of A (Highest Rating). The Value Trend Rating reflects highly consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Corbus Pharmaceuticals Holdings has a good Appreciation Score of 82 and a very high Power Rating of 86, leading to the Highest Value Trend Rating.

Rating Review

In light of this highly negative price change we are reviewing our current Overall Rating of A. This review will be completed in the next several days.

Be the first to comment

Leave a Reply

Your email address will not be published.